Pharmaceutical Commerce - October 2022

Click the title above for a link to open the Pharmaceutical Commerce October 2022 issue in an interactive PDF format.

Decision-making technologies come to the forefront of the AI space

While all drug development efforts are fraught with peril, a growing number of biopharma companies—large and small—are staking a claim in the rare disease treatment space, chasing odds that could yield clinical and financial rewards

The pandemic, which stressed all participants in the pharma cold chain, has not stopped innovation in industry practices, as exploration of the main drivers shows

Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization

Outlining five network-focused ways industry can support cold chain shipping of advanced therapy products

A conversation with dangerous goods expert Jay Johnson

With today's greater combination of technology and know-how, we must design new ways to handle sensitive pharmaceuticals—and do it together

Selecting the appropriate type of temperature-monitoring device starts with understanding the capabilities needed for a specific product

The growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for

Examining the impact of 'new-edge technology'—and Industry 4.0—on pharma track-and-trace warehouse operations

How pharma can speed up the journey with direct-to-patient models

Withstanding fluctuating temperatures along the cold spectrum

New report explores what trends may lie ahead for pharma supply chains